Cargando…
Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
BACKGROUND: This study investigated the effects of metformin on breast density in overweight/obese premenopausal women. METHODS: Overweight/obese premenopausal women (n=120) were randomly assigned to the metformin or placebo group, and all women received lifestyle interventions. The outcomes include...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572728/ https://www.ncbi.nlm.nih.gov/pubmed/34764661 http://dx.doi.org/10.2147/DMSO.S330625 |
_version_ | 1784595274894671872 |
---|---|
author | Leng, Weiling Pu, Danlan Jiang, Juan Lei, Xiaotian Wu, Qinan Chen, Bing |
author_facet | Leng, Weiling Pu, Danlan Jiang, Juan Lei, Xiaotian Wu, Qinan Chen, Bing |
author_sort | Leng, Weiling |
collection | PubMed |
description | BACKGROUND: This study investigated the effects of metformin on breast density in overweight/obese premenopausal women. METHODS: Overweight/obese premenopausal women (n=120) were randomly assigned to the metformin or placebo group, and all women received lifestyle interventions. The outcomes included weight, BMI, FPG, FIN, glucose, HOMA-IR, LDL-C, HDL-C, TG, TC, SBP, DBP, FSH, E, AD, and the BIRADS grade, and the incidence of breast cancer was assessed by pathological biopsy and BIRADS grade greater than 4. RESULTS: In total, 120 overweight/obese women completed the 1-year trial. Seven patients had a BIRADS grade greater than 4, including 5 patients who were biopsy positive, in the control group, and 2 patients had a BIRADS grade greater than 4, including 1 patient who was biopsy positive, in the metformin group. Compared with those in the control group, the body weight, BMI, FIN, FPG, HOMA-IR, TC, BIRADS grade and positive pathological biopsy rate in the metformin group were significantly decreased (P<0.05), while AD was significantly increased (P<0.05). The correlation analysis indicated that the BIRADS grade was significantly correlated with weight, BMI, FPG, FIN, HOMA-IR, SBP, AD and the positive pathological biopsy rate, and the positive pathological biopsy rate was significantly correlated with weight, BMI, HOMA-IR, SBP, AD and BIRADS grade. The logistic regression analysis revealed that the BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD and that the positive pathological biopsy rate was significantly correlated with the BIRADS grade. CONCLUSION: As adjunctive therapy, the combination of lifestyle changes and metformin was found to be a safe strategy for improving related metabolic markers and increasing adiponectin. The BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD, and the positive pathological biopsy rate was significantly correlated with the BIRADS grade. |
format | Online Article Text |
id | pubmed-8572728 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85727282021-11-10 Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women Leng, Weiling Pu, Danlan Jiang, Juan Lei, Xiaotian Wu, Qinan Chen, Bing Diabetes Metab Syndr Obes Clinical Trial Report BACKGROUND: This study investigated the effects of metformin on breast density in overweight/obese premenopausal women. METHODS: Overweight/obese premenopausal women (n=120) were randomly assigned to the metformin or placebo group, and all women received lifestyle interventions. The outcomes included weight, BMI, FPG, FIN, glucose, HOMA-IR, LDL-C, HDL-C, TG, TC, SBP, DBP, FSH, E, AD, and the BIRADS grade, and the incidence of breast cancer was assessed by pathological biopsy and BIRADS grade greater than 4. RESULTS: In total, 120 overweight/obese women completed the 1-year trial. Seven patients had a BIRADS grade greater than 4, including 5 patients who were biopsy positive, in the control group, and 2 patients had a BIRADS grade greater than 4, including 1 patient who was biopsy positive, in the metformin group. Compared with those in the control group, the body weight, BMI, FIN, FPG, HOMA-IR, TC, BIRADS grade and positive pathological biopsy rate in the metformin group were significantly decreased (P<0.05), while AD was significantly increased (P<0.05). The correlation analysis indicated that the BIRADS grade was significantly correlated with weight, BMI, FPG, FIN, HOMA-IR, SBP, AD and the positive pathological biopsy rate, and the positive pathological biopsy rate was significantly correlated with weight, BMI, HOMA-IR, SBP, AD and BIRADS grade. The logistic regression analysis revealed that the BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD and that the positive pathological biopsy rate was significantly correlated with the BIRADS grade. CONCLUSION: As adjunctive therapy, the combination of lifestyle changes and metformin was found to be a safe strategy for improving related metabolic markers and increasing adiponectin. The BIRADS grade was significantly correlated with the positive pathological biopsy rate and AD, and the positive pathological biopsy rate was significantly correlated with the BIRADS grade. Dove 2021-11-03 /pmc/articles/PMC8572728/ /pubmed/34764661 http://dx.doi.org/10.2147/DMSO.S330625 Text en © 2021 Leng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Clinical Trial Report Leng, Weiling Pu, Danlan Jiang, Juan Lei, Xiaotian Wu, Qinan Chen, Bing Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women |
title | Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women |
title_full | Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women |
title_fullStr | Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women |
title_full_unstemmed | Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women |
title_short | Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women |
title_sort | effect of metformin on breast density in overweight/obese premenopausal women |
topic | Clinical Trial Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572728/ https://www.ncbi.nlm.nih.gov/pubmed/34764661 http://dx.doi.org/10.2147/DMSO.S330625 |
work_keys_str_mv | AT lengweiling effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT pudanlan effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT jiangjuan effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT leixiaotian effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT wuqinan effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen AT chenbing effectofmetforminonbreastdensityinoverweightobesepremenopausalwomen |